Reg. No. 1C 24/47 (N). Each tablet contains 10 mg ezetimibe,
Sponsors
International Bio Service Co., Ltd.
Conditions
Bioequivalence study,Male and female,
Phase 1
Open Label, Randomized, Two-way Crossover, Two-sequence, Two-period, Two-treatment Bioequivalence Study of Ezetimibe Tablets 10mg in Healthy Thai Volunteers
Active, not recruitingTCTR20161219002
Start: 2017-06-05Updated: 2026-03-30
Open Label, Randomized, Two-way Crossover, Two-sequence, Two-period, Two-treatment Bioequivalence Study of 10 mg Ezetimibe Tablet Preparations in Healthy Thai Volunteers
Active, not recruitingTCTR20170122001
Start: 2018-02-01Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Ezetimibe 10 mg Tablets and Reference Product (EZETROLâ„¢ 10 mg) in Healthy Thai Volunteers under Fasting Condition
Active, not recruitingTCTR20171031003
Start: 2018-04-23Updated: 2026-03-30